Robert Mader has extensive experience in the field of toxicology and preclinical safety, holding senior positions at multiple pharmaceutical companies. At Roche, Robert served as Senior Principal Scientist and Principal Scientist, leading toxicology projects from April 2020 to July 2021. Prior to that, Robert was with Debiopharm International SA from July 2010 to April 2020, where roles included Associate Principal Scientist in Preclinical Safety and Senior Scientific Officer. Robert also worked at Novartis as a Labhead focusing on in-vivo pharmacokinetic/pharmacodynamic profiling and has a background as a postdoctoral researcher in communication. Robert earned a Ph.D. in Molecular Biology and a degree in Pharmacy from Ludwig-Maximilians-Universität München.
This person is not in the org chart
This person is not in any teams
This person is not in any offices